About MRL Pharma Private Limited
Data last updated:
MRL Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC362594. Its GSTIN is 07AANCM3700B1ZW (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shobhit Tyagi and Ahsan Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 35/4 Basement, Okhla Industrial Area Phase 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.58 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹12.88 Lakh (net margin 2%) and EBITDA of ₹37.23 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 109% over three years.
The company is associated with 1 brand: MRL Pharma. As per MCA filings, the company has open charges of ₹3.06 Cr and satisfied charges of ₹60 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
For more details, the company can be reached via its website mrlpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF – 35/4 Basement, Okhla Industrial Area Phase 2, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of MRL Pharma Private Limited
The main business activity of MRL Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MRL Pharma Private Limited FY 2024 filings available
MRL Pharma Private Limited reported revenue of ₹6.58 Cr (up 56% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of MRL Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 109% over three years, including 56% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MRL Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37.23 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.88 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MRL Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MRL Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of MRL Pharma Private Limited
MRL Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anil Medicos Pvt Ltd | ₹6.61 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Haryana, India |
| Igt Pharma Private Limited | ₹6.6 Cr (FY 2024) | •••• | •••• | •••• | Vadodara, Gujarat, India | |
| Vanila Dermologie Private Limited | ₹6.6 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Rite Drug Mart Health Services Private Limited | ₹6.59 Cr (FY 2023) | •••• | •••• | 23.0% | •••• | Chennai, Tamil Nadu, India |
| Cambindia Biotech Kits Private Limited | ₹6.59 Cr (FY 2025) | •••• | •••• | -45.0% | •••• | Mumbai, Maharashtra, India |
| MRL Pharma Private Limited this company | ₹6.58 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | New Delhi, Delhi, India |
| Rahi Care Daksa Private Limited | ₹6.58 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Chandigarh, India |
| Poshan Nutriwell Private Limited | ₹6.58 Cr (FY 2024) | •••• | •••• | -34.0% | •••• | Ahmedabad, Gujarat, India |
| Herbatone Specialities Private Limited | ₹6.57 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Nagpur, Maharashtra, India |
| Edifice Life Sciences Private Limited | ₹6.55 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Gurgaon, Haryana, India |
| Allen Biopharma Limited | ₹6.55 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below MRL Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of MRL Pharma Private Limited
MRL Pharma Private Limited is audited by ANSHIKA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANSHIKA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of MRL Pharma Private Limited
MRL Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobhit Tyagi Also directs: MSP Healthcare Private Limited, Drashika Health and Seva Foundation, Finxbiz Associates LLP and 2 more | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Ahsan Ahmad | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of MRL Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MRL Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2025 | Others | ₹1 Cr | Open |
| 14 Jun 2024 | Yes Bank Limited | ₹1.5 Cr | Open |
| 29 Jan 2024 | Others | ₹56.2 Lakh | Open |
| 27 Jul 2022 | Hdfc Bank Limited | ₹60 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of MRL Pharma Private Limited
MRL Pharma Private Limited has 2 court cases on record: 2 filed by MRL Pharma. All cases are disposed. Status as checked between 28 Sep 2026 and 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed by the company against Cygnus Medicare Private Limited | Disposed |
| District court, South East, Delhi | Civil suit | Filed by the company against Cygnus Medicare Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with MRL Pharma Private Limited
MRL Pharma operates one associated brand: MRL Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services focused on healthcare solutions in India. | mrlpharma.in |
Employees and EPFO Compliance at MRL Pharma Private Limited
Employment history and EPFO contributions of people linked to MRL Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of MRL Pharma Private Limited
MRL Pharma has one previous CIN (Corporate Identification Number): U51909DL2020OPC362594. The current CIN is U51909DL2020PTC362594, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909DL2020PTC362594 | Current |
| U51909DL2020OPC362594 | Previous |
Recent Activity on MRL Pharma Private Limited
MRL Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Khush Naseeb ceased to be Director on 30 May 2022.
Credit Ratings, Litigation & Regulatory Alerts for MRL Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MRL Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MRL Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MRL Pharma Private Limited
MRL Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCM3700B1ZW | Delhi | Active | 01 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MRL Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MRL Pharma Private Limited
MRL Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2020 (6+ years old) and is registered under CIN U51909DL2020PTC362594.
MRL Pharma reported revenue of ₹6.58 Cr for FY 2024 (up 56% YoY).
MRL Pharma has 2 current directors:
- Shobhit Tyagi - Director
- Ahsan Ahmad - Director
MRL Pharma reported a net profit of ₹12.88 Lakh (net margin 2%) and EBITDA of ₹37.23 Lakh (EBITDA margin 5.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MRL Pharma is 109% over three years. In the latest year (FY 2024) revenue rose 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MRL Pharma is 07AANCM3700B1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of MRL Pharma is U51909DL2020PTC362594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MRL Pharma has 2 court cases on record: 2 filed by the company.
MRL Pharma was incorporated on 04 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of MRL Pharma by revenue are Anil Medicos Pvt Ltd, Igt Pharma Private Limited, Vanila Dermologie Private Limited, Rite Drug Mart Health Services Private Limited, Cambindia Biotech Kits Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Khush Naseeb ceased to be Director on 30 May 2022. Ahsan Ahmad was appointed as Director on 01 Apr 2022. Shobhit Tyagi was appointed as Director on 01 Apr 2022.